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Abstract
Binuclear rhodium(II) complexes [Rh2CI2(-OOCR)2(N-N)2] {R H, Me; N-N 2,2’-bipyridine (bpy), 1,10-
phenanthroline (phen)} and [Rh2([t-OOCR)2(N-N)2(H20)2](RCOO)2 (R Me, let;) have been synthesized
and their structure and properties have been studied by electronic, IR and 1H NMR spectroscopy.
Antibacterial activity of these complexes against Escherichia coli and Staphylococcus aureus has been
investigated. The most active antibacterial agents against E. coli were [Rh2C12(t-OOCR)2(N-N)2] and
[Rh2(-OOCR)2(N-N)2(H20)2](RCOO)2 {R H and Me} which were considerably more active than the
appropriate nitrogen ligands. The complexes show low activity against S. aureus. The activity of the
complexes [Rh(OOCR):(N-N):(H:O)2](OOCR)2 against E. coli decreases in the series: R H CH3 >
C2H5 > C3H7 -= C4H9. The reverse order was found in the case of S. aureus.
Introduction
Binuclear rhodium(II) tetracarboxylato complexes [Rh2(/-OOCR)4L2] as well as complexes
containing two bridging ligands [Rh2X2(/-OOCR)2(N-N)2] and [Rh2(/-OOCR)2(N-N)2L2]2+, where L
Lewis base, X halide and N-N 2,2’-bipyridine, 1,10-phenanthroline and their derivatives have aroused
considerable interest because of interesting structure and reactivity 1-9], catalytic properties 4, 10] and
anticancer activity 4, 11 17]. The antitumor activity of Rh2(OOCR)4 complexes intensified studies of
their interaction with biomolecules, e.g. aminoacids, peptides, vitamins, nucleic acid bases, adenosine
phosphates, DNA, etc. [1 4, 12, 14 21]. Tetraacetatodirhodium(II) [20] and
[Rh2(OOCCH3)2(bpy)2(H20)2](OOCCH3)2 [21] bind effectively to human serum albumin via imidazole
rings leading to the conformational changes of HSA.
It has been found [22] that [Rh2(OOCR)2(N-N)2(H20)2]2+ complexes show cytostatic activity for
human oral carcinoma KB cell line in vitro. Some of the determined biological activities were in close
relation with findings obtained on synchronous cultures of green algae exposed to these Rh(II) complexes
[23]. New metal compounds possessing antimicrobial activity are recently intensively investigated because of
increasing resistance of microbes against many antibiotics. It has been found that some platinum complexes
possessing antitumor activity show also antibacterial properties. A further well defined series of metal
complexes with antibacterial activity is that of rhodium(III) coordination compounds of formula trans-
[RhX2(py)4]Y [24 26]. These complexes are more active against Gram-positive microorganisms than Gram-
negative ones but where Gram-negative bacteria, such as E. coli, are susceptible the inhibitory concentrations
are approximately the same. The most lipophilic rhodium complexes are the most bacteriostatic, this perhaps
correlating with penetration. However, we have found that some dimeric rhodium(II) complexes
[Rh2(OOCR)2(N-N)2(H20):z]2+ (N-N bpy, phen, 6,7-dimethyl-2,3-bis(2-pyridyl)quinoxaline, R
CH2CH2CH3, CH2(CH2)2CH3, CH(OH)Ph, Ph) are considerably more active against Gram-positive than
against Gram-negative bacteria [27]. The complexes [RhC12(bpy)2]/ are not active antibacterial agents,
perhaps because they possess the cis-configuration [24- 26].. In this paper, we report on synthesis and
properties of dimeric rhodium(II) complexes [Rh2(OOCR):z(N-N)2(H:zO):]:+ and [Rh2CI:z(OOCR):z(N-N)2]
(R H, CH3, CH:zCH3, N-N 2,2’-bipyridine, 1,10-phenanthroline) which are much more active against
Gram-negative than against Gram-positive bacteria.
Experimental
Synthesis of the complexes.
Complexes [Rh2(OOCCH3)4(H20)2] [28], Na4[Rh2(CO3)4].2.SH20 [29],
[Rh2(OOCCH3)2(phen)2(H20)2](OOCCH3)2 (1) [23], [Rh2Cl2(OOCH)2(phen) 2] (2) [5, 7],
[Rh2CI2(OOCCH3)2(phen)2] (3) [22], [Rh2CI2(OOCCH3)2(bpy)2] (5) [22],
[Rh2(OOCCH3)2(dmpq)2(H20)2](OOCCH3)2 (9) [27] and [Rh2(OOCPh)2(phen)2-(H20)2](OOCPh)2 (10)
[27], [Rh2(OOCCH2CH2CH3)2(bpy)2(H20)2](OOCCH2CH2CH3)2 (11) [27],
[Rh2{OOC(CH2)3CH3}2(phen)2(H20)2]{OOC(CH2)3CH3}2 (12) [27] and
[Rh2{OOC(CH2)3CH3 }2(bpy)2(H20)2] OOC(CH2)3CH3 }2 (13) [27] were prepared by literature methods.
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1,10-Phenanthroline (phen), 6,7-dimethyl-2,3-bis(2-pyridyl)quinoxaline (dmpq) and 2,2’-bipyridine
(bpy) were obtained from Aldrich and used without further purification.
[Rh2(OOCCH3)2(bpy)2(H20)2](OOCCH3)2 (4). A solution of [Rh2(OOCCH3)a(H20)2] (0.239 g,
0.5 mmol) and 2,2’-bipyridine (0.156 g, mmol) in 5 cm3 of dioxane was heated at reflux for 3 h, cooled to
the room temperature and brown precipitate has been filtered out. The product has been dissolved in ethanol
(2 cm3) and pure dark red complex 4 has been deposited by means of diethyl ether. Precipitate was filtered
off, washed with (C2H5)20 and dried under reduced presure, yield 0.296 g, 75%. Anal. Calc. for
C28H32N4OIoRh2: C 42.55, H 4.08, N 7.09. Found: C 42.16, H 4.25, N 6.90.
[Rh2(OOCCH2CH3)2(phen)2(H20)z](OOCCH2CH3)2.2H20 (6). A solution of
[Rh2(OOCCH2CH3)4(H20)2] (0.1335 g, 0.25 mmol, and phen (0.099 g, 0.5 mmol) was heated in ethanol (7
cm3) for 2 h, cooled to the room temperature and filtered in atmosphere of air. The brown-red precipitate was
deposited by means of diethyl ether. The product was washed with ether and dried in vacuo, yield 0.159 g,
71%. Yield was approximately the same when 1,4-dioxane or isopropanol were used as a solvent. Anal. Calc.
for: C36H44N4OI2Rh2:: C 46.47, H 4.77, N 6,02. Found: C 46.10, H 4.82, N 5.96.
[Rh2(OOCCH2CH3)2(bpy)z(H20)2](OOCCHzCH3)2 (7). A solution of
[Rh2(OOCCH2CH3)4(H20)2] (0.1335 g, 0.25 mmol, and bpy (0.078 g, 0.5 mmol) was heated in ethanol
10 cm3) for 2 h. The solution was evaporated to dryness and compound was recrystallized from iso-propanol-
tert-butanol (1 2) The red precipitate was washed with diethyl ether and dried in vacuo, yield 0.134 g, 63%.
Isopropanol and 1,4-dioxane may be also used as solvents instead of ethanol. Anal. Calc. for
C32H40N4OIoRh2: C 45.40, H 4.76, N 6.62. Found: C 45.70, H 4.68, N 6.70.
[Rh(OOCCH2CH3)4(H20)2]. (8). A mixture of Na4[Rh2(CO3)4].2.5H20 (0.583 g, mmol) and
propionic acid (0.593 g, 8 mmol) in water 10 cm3) was heated at 100 oC for 2 h. The green product was
collected and washed with water and methanol and dried in vacuo, yield 0.411 g, 0,77%. Anal. Calc. for
C2H2400Rh2: C 28.94, H 4.05. Found: C 28.70, H 3.96.
Physical measurements.
Infrared spectra (KBr pellets and nujol mulls) were measured on a Perkin Elmer 283 and a Bruker
IFS 113v, UV-VIS on a CarT 5 and Beckman DU 7500, and IH NMR spectra on a BrukerAMX 300.
Antibacterial activity.
The antibacterial activity was evalueted on reference strains Staphylococcus aureus 209P (Oxford)
and Escherichia coli K-12 ROW. Nutrient broth and nutrient agar (Biomed, Warszawa) as growth and
plating media were used, respectively. The media were supplemented with the tested compounds at suitable
concentrations. The growth of bacteria was determined after 24 hours incubation at 37 oC. Antibacterial
activity was determined either as MIC (minimal inhibitory concentration) (in solid medium) or by serial
dilution in nutrient broth by the method presented in the previous paper [27]. In the former about one
hundred colony forming units per plate were plated; in the latter 10 cm3 of broth was inoculated with either
108 or 105 colony forming units.
In experiments on mutagenicity of the complexes the test recommended by Ames and Maron [30]
was carried out using TA 97, TA 98, TA 100 and TA 102 as bio-his- mutants of Salmonella typhimurium.
Results and Discussion
The [Rh2(RCOO)2(N-N)2(H20)2][RCOO]2 complexes were prepared by reactions between
[Rh2(RCOO)4(H20)2 and appropriate nitrogen ligand in ethanol, 2-propanol and 1,4-dioxane. Other
alcohols may be also used. The reactions in primary and secondary alcohols should be performed in the
presence of air because rhodium(II) complexes during heating in these solvents are reduced to the deep green
or green-blue rhodium(I) compounds which are very easily reoxidized to Rh(II) complexes with oxygen or
air. Thus, the [Rh2(RCOO)2(N-N)2(H20)2][RCOO]2 complexes can be used for oxidation of alcohols to
carboxylic acid. The propionato complexes during prolongated heating in ethanol in the presence of air can
be partly converted into appropriate acetates because of oxidation of C2HsOH. Therefore syntheses of the
[Rh2(RCOO)2(N-N)z(H20)2][RCOO]2 and [RhzClz(RCOO)z(N-N)2 complexes in alcohols should be
carried out in neutral atmosphere and rhodium(I) compounds formed after heating of the reaction mixture
should be immadiately cooled and oxidized to the binuclear Rh(II) complexes with air and deposited. The
[Rh2CI2(RCOO)2(N-N)2 complexes can be prepared analogously in the presence of stoichiometric amounts
ofNaCl [5, 7, 22]. The [Rhz(RCOO)z(N-N)z(H20)z][RCOO]2 and [Rh2C12(RCOO)z(N-N)2 compounds are
stable under air atmosphere both in solid state and in solutions. The [Rh2(RCOO)z(N-N)2(H20)z][RCOO]2
complexes are readily soluble in water, methanol and ethanol and slightly soluble in higher alcohols,
insoluble in diethyl ether, 1,4 dioxane and nonpolar solvents. Solubility of the [RhzClz(RCOO)2(N-N)2
compounds in the same solvents is lower. All complexes have been characterized by a combination of
elemental analysis and IR, UV-VIS and 1HNMR spectroscopy. The data are collected in Tables 1-3.
The [Rhz(RCOO)z(N-N)z(HzO)z][RCOO]2 compounds as well as chloro complexes
[RhzC12(OOCR)2(N-N)2] in solutions in methanol give conductivities in the 100 50 ohm-..cmZ.mol-1
range. Thus [Rh2C12(OOCR)2(N-N)2 complexes show incomplete substitution of chloro for H20 or CH3OH
ligands and in solution concentration of [RhzCl(OOCR)z(phen)2(H20)]+ ions is relatively high. This was
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also confirmed by the presence ofCIRh CT bands in the electronic spectra of these compounds in the 290
255 nm [4, 5, 31].
In the electronic spectra (Table 1) of these complexes in visible region two bands are observed.
Band occurs at about 555 -570 nm, about 20 30 nm lower compared with that for [Rh2(RCOO)4(H20)2
compounds because this band corresponds to the *(Rhz)(y*(Rh2) transition [1 5, 31] and the *(Rh2)
levels in [Rhz(RCOO)z(N-N)z(H20)2]2+ complexes due to the interaction of the orbitals of the Rh2 core
with n* orbitals of nitrogen ligands have lower energy than that of the n* (Rhz)(5.eg) orbitals in
[Rhz(OOCR)4(H20)2 compounds. The intense band II at about 408 420 nm was assigned to the allowed
charge-transfer transition J(Rhz)*(N-N) [31]. This band obscures the absorption of low intensity
attributed to the *(Rhz)Qy*(Rh-O transition observed at 430 460 nm in [Rh2(OOCR)4(H20)2]
complexes. The energy of the band strongly depends on the nature of axial ligands and encreases with
increasing of the field strength of these ligands. Band remains relatively constant for axial oxygen donor
ligands, but is blue shifted with nitrogen donor ligand.
Table 1. Electronic Spectra of Rhodium(II) Complexes.
Compound Band, )(e), Inm](M-lcm-l)
3 in H20
4 in H20
5 in H20
6 in H20
7 in H20
562(200), 408(2550), 366sh(3850), 334sh(5200), 268(29200), 252(30800), 233(19000)
564(340), 416(2400), 362(700), 305(14800), 270(30200),"257(32400)
559(270), 416(2600), 356(3800), 325sh(8200), 303sh(16800), 268(31200), 255(31200),
227sh(12800)
560(290), 411 (2500)sh, 360(4300)sh, 332(5100)sh, 271 (31600), 253(39300),
224(46300)
560(380), 420(2300), 361 (3500), 304(15100), 270(29600)sh, 259(31800),
Table 2. IR S of Rhodium.
Comp v(CH) Vas(CO) vs(COO)
lex [cm-l] [cm-lJ [cm-lj
1 3090vw, 3058w, 1595vs, 1582vs, 1445sh, 143Ors,
3000vw, 2925vw 1560vs 1412vs
4 3115w, 3080w, 1602m, 1578vs, 1445vs, 1418vs,
3040vw, 2990vw, 1560vs 1400vs
2930vw
3060w, 3010vw, 1594s, 1565sh, 1460s, 1425vs,
2985m, 2930w, 1550vs 1405vs, 1372s,
2920w, 2880vw 1360s
3115w, 3075m,
3060w, 3025w,
2985m, 2960w,
2940sh, 2925m,
2875w
1600sh, 1562vs, 1463s, 1446s,
1550vs 1320s, 1380m,
1362m
2987m, 2980m,
2945m, 2920w, 2880
1568vs 1470s, 1462s,
1450m, 1420vs
other bands
[cm-l]
1520m, 1494w, 1360s, "i323s,
1222w, 1205w, 1147w, 1112vw,
1090vw, 1048w, 1020w, 841s,
766w, 724sh, 715s, 703s, 648m,
622w, 516w, 480vw, 440vw
1488w, 1464m, 1350w, 1332w,
1305w, 1268vw, 1243w, 1152w,
1120vw, 1102vw, 1062vw, 1040w,
lO12w, 914w, 762s, 718m, 699s,
642m, 620w, 460vw, 415w
15lOw, 1490vw, 1337w, 1294m,
1276m, 1222w, 1205w, 1142w,
11 lOvw, 1088vw, 1070m, 1033w,
lOlOw, 892m, 878w, 867w, 850sh,
836s, 822vw, 807w, 767vw,
742vw, 7lOs, 678vw, 650vw,
610vw, 510vw, 433vw, 408vw,
386vw, 372vw, 324vw
1490vw, 1305s, 1280s, 1246w,
1170m, 1162m, 1121vw, 11 lOw,
1073m, 1042vw, lO12w, lO01vw,
898m, 863m, 808m, 765vs, 720s,
699w, 678vw, 644w, 612w, 515w
br, 418m,.408sh, 375vw, 345vw,
328vw
1382m, 1370s, 1299vs, 1242m,
1187m, 1179m, 1170m, 890m,
804m, 745w, 710m, 677s, 632vw,
432m, 410m, 352s
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The IR spectra of complexes with phenanthrolines confirmed that carboxylato ligands are
symmetrically bonded to the both rhodium atoms because differences between vas(COO) and vs(COO) are
small (Table 2).
The chemical shifts of protons of carboxylato ligands in [Rh2(RCOO)2(N-N)2(H20)2]2+ are higher
than those of non-coordinated carboxylates and RCOO groups in Rh2(OOCR)4(H20)2 complexes. The
highest coordination shift is observed for protons bound with corboxylic group.The Rh H coupling was
observed only in the case of formato complexes for which 3JRhH is ca 4 Hz. The 1,10-phenanthroline and
2,2’-bipyridine ligands in [Rh2(OOCR)2(phen)2(H20)2](OOCR)2, [Rh2(OOCR)2(bpy)2(H20)2](OOCR)2,
[RhzClz(OOCR)z(phen)2] and [RhzCIz(OOCR)z(bpy)2] (R H, alkyl) are symmetrically bound to the
rhodium atoms. This is proven by the presence only 4 signals of hydrogen atoms of heterocyclic nitrogen
ligands in the 1HNMR spectra ofthese complexes (Table 3).
Table 3. H NMR Spectra of Rhodium(II) Complexes.
Compound
1 in D20
2 in D20
3 in D20
4 in D20
5 in D20
6 in D20
7 in D20
8 in D20
nc noncoordinating ion, c coordinating ligand, m complex pattern
5, ppm (J, Hz)
1.849s(CH3nc), 2.624s(CH3c), 7.558dd(H3,J23=5.3 Hz, J34=8.0 Hz), 7.658s(HS),
8.224dd(H4, J24 1.1 Hz), 8.455d(H2)
7.464 dd(H3, J23 5.3 Hz, J34 8.3 Hz), 7.55/s(H5), 8.127d(H4), 8.355t(HCOO, JRhH
4.1Hz), 8.419d(H2)
2.536s(CH3), 7.452dd(H3, J23 5.4 Hz, J34 8.3 Hz), 7.55Is(H5), 8.113dd(H4, J24 0.8
Hz), 8.348d(H2)
1.804s(CH3nc), 2.456s(CH3c), 7.290ddd(H5,J56=5.8 Hz, J45=7.0 Hz, J35
1.8 Hz ), 7.77-7.86m (H3+H4), 8.203d(H6)
2.418s(CH3), 7.249ddd(HS, J56 5.6 Hz, J45 7.3 Hz), 7.729 7.81 lm(H3+H4),
8.159d(H6)
0.932t(CH3nc, 3JHH 7.7 Hz), 1.339t(CH3c, 3JHH 7.6 Hz), 2.056q(CH2nc, 3JHH 7.7
Hz), 2.823q(CH2c, 3JHH 7.6 Hz), 7.487dd(H3,J23 5.3 Hz, J34 8.3 Hz), 7.594s(HS),
8.156dd(H4, J24 1.0 Hz), 8.35 ld(H2)
0.933t(CH3nc, 3JHH 7.7Hz), 1.244t(CH3c, 3JHH 7.6 Hz), 2.058q(CH2nc, 3JHH 7.7
Hz), 2.699q(CH2c, 3JHH 7.6 Hz), 7.268ddd(HS, J45=7.0, J56=5.7 Hz), 7.75-
7.84m(H3+H4), 8.146d(H6)
1.114t(12H, CH3, 3JHH 7.6 Hz), 2.272q(8H,. CH2)
2+
R
H20 Rh
N RhO
R
oC /R .o
C1
Rh 0
Rh
C1
N 1N/
Fig. 1. Structure of [Rh2(OOCR)2(N-N)2(H20)2]2+ and [Rh2CI2(OOCR)2(N-N)2 complexes
Thus, the physicochemical measurements indicate that structure of [Rh2(OOCR)2(N-
N)2(H20)2](OOCR)2 complexes is analogous to that of [Rh2CI2(RCOO)2(N-N)2 [4, 5, 7] with symmetric
carboxylato bridges and water molecules coordinating along Rh-Rh axis (Fig. 1).
The complexes 1 7 and the ligands (phen and bpy) were tested in vitro for antibacterial activity
against Gram-negative Escherichia coli ROW and Gram-positive Staphylococcus aureus 209 P (Oxford)
strains (Table 4). The highest activity against Gram-negative bacteria exhibited complexes 1 5 and
compounds 6 and 7 are a little less active, however, they are considerably more active than the appropriate
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nitrogen ligands. They are active at concentrations 5.10-6 10-5 M. All complexes (1 7) show rather low
activity against S. aureus.
For some [Rh2(OOCR)2(N-N)2(H20)2](OOCR)2 and [Rh2C12(RCOO)2(N-N)2] complexes
characteristic is high selectivity against Gram-negative or Gram-positive bacteria. In general, Gram-positive
microorganisms are more susceptible than gram-negative ones, the minimal inhibitory concentrations are
usually ten times lower for the former (10-6 M) than for the latter (10-5 M). The activity of the complexes
[Rh2(OOCR)2(N-N)2(H20)2]-(OOCR)2 against E. coli decreases in the series: R H CH3 > C2H5 > C3H7
-= C4H9. The reverse order was found in the case of S. aureus. Thus, [Rh2(OOCR)2(N-N)2-(H20)2](OOCR)2
complexes with the most hydrophobic R group are the most active against S. aureus [27], this presumably
correlating with penetration. This was also confirmed for analogous complexes containing PhCOO and
PhCH(OH)COO ligands [27]. The data given in the Table 4 indicate that the most hydrophilic
[Rh2(OOCR)2(N-N)2(H20)2](OOCR)2 complexes are the most active against E. coli.
Table 4. Viable count of E.coli K-12 ROW and S. aureus P-209 OXFORD in the presence of binuclear
rhodium complexes in solid aar medium
Complex Percent of c.f.c.
No
phen
control
concentra-
tion, M
1.10-5
5.10-6
2.5.10-6
1.10-5
2.10-6
1.10-5
2.10-6
1.10-5
1.10-5
1.10-5
0
E.coli S. aureus
0
0
80
0
80
0
82
0
0
0.9
37
100
100
90
100
66
100
90
95
100
21
100
Complex
No concentra-
tion, M
7 1.10-5
10
11
12
13
bpy
dmpq
1.10-5
2.5.10-6
1.10-5
1.25.10-6
1.10-5
1.10-5
5.10-6
1.10-5
5.10-6
1.10-4
1.10-4
Percent of c.f.c.
E.coli S. aureus
4.0
100
100
lO0
100
100
74
60
4O
0
0
0
2.5
0
0
0
0
0
34
33
In order to get more information about the nature of the inhibitory activity of the investigated
compounds, we have examined the dependence of survival of E. coli in nutrient broth containing complexes
1 and 4 at 37 0C on time (Fig. 2).
A B
ncubauon lm e. m]
[aconol uppleenll ,11 tom plex[
Fig. 2. Survival of E. coli K-12 ROW in nutrient broth supplemented with 1.10-5 M of complex 1 (A) and
complex 4 (B).
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It is known that some antibacterial drugs, like -lactamase are active only against growing bacteria
[32]. The fast decrease of c.f.c. (colony forming cells) with time indicates that the complexes show
bactericidal activity against E. coli K-12 ROW. The bactericidal activity was also confirmed by analogous
tests performed in saline containing complexes 1 and 4 (10-5 M) at 37 0C. The results given in Table 5
indicate that in these experiments the decrease of survival is also observed, although this decrease is not so
strong as in the case of broth cultures.
The effectivity ofmany antibiotics and chemoterapeutic agents depends on the size ofthe population
of treated microorganisms. Moreover, the probability of growth ofthe mutated cells increases with inoculum
size. Therefore, the survival of E. coli cultures in broth over the population range 105 to 108 cells in the
presence of complexes 1 7 has been determined. The results presented in Table 6 indicate that the
bactericidal activity of these compounds depends on the inoculum size. The complexes 1, 3 and 5 7 are
active at concentration equal to or greater than 5.10-5 M in broth inoculated with 108 cells, while 2 is
effective at 2.5.10-5 M. The lowest activity, at this inoculum size, shows complex 4. The complexes 1 7
inhibited the growth of E. coli in broth at concentration at least for one order lower when the inoculum size
was 105 cells.
Table 5. Survival of E.coli K-12 ROW in saline supplemented with the complexes 1 and 4
Time of
incubation
0
3
6
24
Unsupplemented
c.f.c./cm3
1,3.103
9,6.102
1,0.103
9,2.102
% of survival
100
74
77
71
c.f.c. colony forming cells
Saline
Supplemented with x 10-5 M of complex
complex 1
c.f.c./cm3 % of survival
2,8.102 100
1,2.102 43
1,5.102 54
6,0.101 21
complex 4
c,f.c./cm3 % of survival
1,4.103 100
1,1103 79
9,5.102 68
3,4.102 24
The [Rh2(OOCR)2(N-N)2(H20)2](OOCR)2 and [Rh2C12(RCOO)2(N-N)2] complexes belong to coordination
compounds showing rather high antibacterial activity against E. coli and particularly against S. aureus [27]
and they can be considered as the antibacterial agents with possible application. Therefore, it seemed
interesting to investigate the mutagenicity some of these compounds. The performed tests ofAmes (Table 7)
indicate that the number of the his+bio+ revertants of Salmonella typhimurium strains on plates containing
complexes 1 7, 8 and 10 at concentration equal to MIC is n6t greater than that on control plates.
Table 6. Dependence of growth of E.coli K-12 ROW in broth supplemented with rhodium(II) complexes
on inoculum size.
Com Inocu
plex lum
size
1.10-4 5.10-5 2,5.10-5
1 108 -/+ -/+
3 -/+ -/+
4 + +
5 -/+ +
6 -/+ +
7 -/+ +
1 105
+ g{owth as in control;- no growth
Concentration of the complex, (M)
1,25.10-5 6,25.10-6 3,125.10-6 1,56.10-6 0
+ + + + +
+ + + + +
+ + + + +
+ + + + +
+ + + + +
+ + + + +
+ + + + +
+ +
_/+ + + +
/ +
+ + +
/ +
+ + + +
+ + + +
-/+ growth scarcely visible
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_Table 7. Test of Ames on mutagenic
Complex Concentration of
2
3
4
5
6
7
9
10
control
complex
1.10-5
1.10-5
5.10-5
1.10-5
1.10-5
1.10-5
1.10-5
5.10-6
215.10-6
0
ty of rhodium(II) complexes.
Mean number of his+bio+ revertants
TA97
183
186
97
199
115
187
192
232
215
238
in the strains S. typhimurium
TA98 TA100
45
49
12
53
48
52
43
49
41
54
56
TAi02
364
326
326
462
293
446
449
442
491
665
The lower number of revertants in the presence of complexes are to be expected because at MIC
concentration of complexes some of the treated cells are killed. It is difficult to determine the fraction of
survivals in these experiments because it depends on inoculum size. Nevertheless, the tested complexes seem
to be rather safe from the point ofview of mutagenicity.
Acknowledgements
The authors are grateful to the KBN for support of this work (grant No. 2 P303 02005).
References:
[1] F.A. Cotton, R.A.Walton, Multiple Bonds Between Metal Atoms, Clarendon Press, Oxford, 1993;
[2] E.B. Boyar, S.D. Robinson, Coord. Chem. Rev., 50, 109(1983);
[3] T.R. Felthouse, Progr. Inorg. Chem., 29, 73(l 982).
[4] F. Pruchnik, Pure Appl. Chem., 61,795(1989);
[5] F. Pruchnik, B.R. James, P. Kvintovics, Can. J. Chem., 64, 936(1986); F. Pruchnik, M. Zuber, H.
Pasternak, K. Wajda, Spectrochim. Acta, 34A, 1111(1978); F.P. Pruchnik, J. Hanuza, K.
Hermanowicz, K. Wajda-Hermanowicz, M. Zuber, ibid.;45A, 835(1989); F. Pruchnik, M. Zuber,
Rocz. Chem., 51, 1813(1977);
[6] F. Pruchnik, A. Jezierski, E. Kalecifiska, Polyhedron, 10, 2551 (1991);
[7] H. Pasternak, F. Pruchnik, Inorg. Nucl. Chem. Letters, 12, 591(1976); T. G:[owiak, F.P. Pruchnik M.
Zuber, Polish J. Chem., 65, 1749(1991);
[8] A. Szymaszek, F.P. Pruchnik, Polish J. Chem., 66, 1859(1992).
[9] J. Halpern, E. Kimura, J. Molin-Case, C.S. Wong, J. Chem. Soc., Chem. Commun., 1207(1971).
[10] H. Pasternak, E. Lancman, F. Pruchnik, J. Mol. Catal., 29, 13(1985); H. Pastemak, F. Pruchnik, K.
Wajda-Hermanowicz, M. Zuber, Polish J. Chem., 63, 619(1986); H. Pasternak, F.P. Pruchnik, Polish
J. Chem., 66, 865(1992).
[11] J.L. Bear, H.B. Gray Jr., L. Rainen, I.M. Chang, R. Howard, G. Serio, A.P. Kimball, Cancer
Chemother. Rep. 59, 611(1975); R.A. Howard, A.P. Kimball, J.L. Bear, Cancer Res., 39,
2568(1979).
[12] K.R. Dunbar, J.H. Matonic, V.P. Saharan, C.A. Crawford, G. Christou, J. Am. Chem. So., 116,
2201(1994).
[13] R.G. Hughes, J.L. Bear, A.P. Kimball, Proc. Am. Assoc. Cancer Res., 13, 120(1972).
14] P.N. Rao, M.L. Smith, S. Pathak, R.A. Howard, J.L. Bear, J. Nat. Cancer Inst., 64, 905(1980).
15] L.M. Hall, R.J. Speer, H.J. Ridgway, J. Clin. Hematol. Onol., 10, 25(1980).
16] E. Tselepi-Kalouli, N. Katsaros, J. Inorg. Biochem., 40, 95(1990).
17] L.D. Dale, T.M. Dyson, D.A. Tocher, D.I. Edwards, Anticancer Drug Res., 4, 295(1989).
18] S. Zyngier, E. Kimura, R. Najjar, Braz. J. Meal Biol. Res., 22, 397(1989).
[19] E.M. Reibscheid, S. Zyngier, D.A. Maria, R.J. Mistrone, R.D. Sinnistera, L.G. Couto, R. Najjar,
Brazil. J. Medic. Biol. Res. 27, 91 (1994); M.S. Nothenberg, G.K. Yakeda, J. Najjar, J.Inorg. Biochem.,
42,217(1991).
[20] L. Trynda, F.P. Pruchnik, J. Inorg. Biochem., 58, 69(1995).
[21 L. Trynda, F.P. Pruchnik, J. Inorg. Biochem., in press.
[22] F.P. Pruchnik, D. Duce, J. Inorg. Biochem., 61, 55(1996);
[23] F.P. Pruchnik, G. Kluczewska, A. Wilczok, U. Mazurek, T. Wilczok, J. Inorg. Biochem., in press; A.
Wilczok, Biological activity ofRhodium complexes in synchronous culture ofChlorella vulgaris. Ph.
D. Thesis, Silesian Academy of Medicine, Katowice, 1990.
[24] R. J. Bromfield, R. H. Dainty, R. D. Gillard, B. T. Heaton, Nature, 223, 735(1969).
87Vol. 4, No. 2, 1997 Binuclear rhodium(II) Colnplexes with Selective Antibacterial Activity
[25] R. D. Gillard, Kem. Kozlemenyek, 47, 107(1977).
[26] N. Farrel, Transition Metal Complexes as Drugs and Chemotherapeutic Agents, Kluwer, Dordrecht,
1989.
[27] F. P. Pruchnik, M. Biefi, T. Lachowicz, Metal-Based Drugs, in press.
[28] G.A. Rempel, P. Legzdins, H. Smith, G. Wilkinson, Inorg. Synth., 13, 90(1972).
[29] C.R. Wilson, H. Taube, Inorg. Chem., 14, 405(1975).
[30] B. N. Ames, D. M. Maron, Mut. Res., 113, 173(1993).
[31 L. Natkaniec, F.P. Pruchnik, J. Chem. Soc., Dalton Trans., 3261(1994).
[32] P. S. Ringrose, in ,,The Scientific Basis ofAntimicrobial Chemotherapy", ed. by D. Greenwood and F.
O’Grady, Cambridge University Press, Cambridge, 1985, pp 219- 266.
Received: September 2, 1996 Accepted: September 15, 1996
Received in revised camera-ready format" March 25, 1997
88